Objective:To investigate the clinical effects of applying the magnetic resonance double mismatch technique to endovascular treatment of acute anterior circulation,large vessel occlusion with cerebral infarction in an ...Objective:To investigate the clinical effects of applying the magnetic resonance double mismatch technique to endovascular treatment of acute anterior circulation,large vessel occlusion with cerebral infarction in an unknown time window.Methods:The research work was carried out in our hospital,the work was carried out from November 2018 to November 2019,the patients with acute anterior circulation large vessel occlusion with cerebral infarction who were treated in our hospital during this period,100 patients,50 patients with an unknown time window and 50 patients with definite time window were selected,and they were named as the experimental and control groups,given different examination methods,were given to investigate the clinical treatment effect.Results:Patients’data on HIHSS score before treatment,the incidence of intracranial hemorrhage and rate of Mrs≤2 rating after 90 days of treatment were not significantly different(P>0.05),which was not meaningful.The differences in data between the two groups concerning HIHSS scores were relatively significant before,and after treatment(P<0.05).Conclusion:The magnetic resonance double mismatch technique will be applied in the endovascular treatment of acute anterior circulation large vessel occlusion with cerebral infarction of unknown time window.展开更多
目的:探究替罗非班联合机械取栓对急性前循环脑梗死患者血管再通率及短期预后的影响。方法:将2018年8月至2022年7月江南大学附属医院收治的85例急性前循环脑梗死患者按治疗方式不同分为对照组(机械取栓治疗;n=41)与研究组(替罗非班联合...目的:探究替罗非班联合机械取栓对急性前循环脑梗死患者血管再通率及短期预后的影响。方法:将2018年8月至2022年7月江南大学附属医院收治的85例急性前循环脑梗死患者按治疗方式不同分为对照组(机械取栓治疗;n=41)与研究组(替罗非班联合机械取栓治疗;n=44)。观察2组临床疗效及短期预后情况,并比较治疗前、后2组血液流变学指标、美国国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS)评分及日常生活能力改良Barthel指数(modified Barthel index,MBI)评分。结果:研究组血管再通率为90.91%,高于对照组的70.73%(P<0.05);2组治疗后红细胞比容、血浆黏度及全血高切黏度均低于治疗前,且研究组低于对照组(均P<0.05);2组治疗后NIHSS评分低于治疗前,MBI评分高于治疗前,且研究组优于对照组(均P<0.05);研究组治疗后90 d预后良好率为68.18%,高于对照组的43.90%(P<0.05);治疗后90 d内,2组颅内出血、再闭塞发生率与病死率比较差异均无统计学意义(均P>0.05)。结论:替罗非班联合机械取栓治疗急性前循环脑梗死的血管再通率更高,有利于短期预后。展开更多
文摘Objective:To investigate the clinical effects of applying the magnetic resonance double mismatch technique to endovascular treatment of acute anterior circulation,large vessel occlusion with cerebral infarction in an unknown time window.Methods:The research work was carried out in our hospital,the work was carried out from November 2018 to November 2019,the patients with acute anterior circulation large vessel occlusion with cerebral infarction who were treated in our hospital during this period,100 patients,50 patients with an unknown time window and 50 patients with definite time window were selected,and they were named as the experimental and control groups,given different examination methods,were given to investigate the clinical treatment effect.Results:Patients’data on HIHSS score before treatment,the incidence of intracranial hemorrhage and rate of Mrs≤2 rating after 90 days of treatment were not significantly different(P>0.05),which was not meaningful.The differences in data between the two groups concerning HIHSS scores were relatively significant before,and after treatment(P<0.05).Conclusion:The magnetic resonance double mismatch technique will be applied in the endovascular treatment of acute anterior circulation large vessel occlusion with cerebral infarction of unknown time window.
文摘目的:探究替罗非班联合机械取栓对急性前循环脑梗死患者血管再通率及短期预后的影响。方法:将2018年8月至2022年7月江南大学附属医院收治的85例急性前循环脑梗死患者按治疗方式不同分为对照组(机械取栓治疗;n=41)与研究组(替罗非班联合机械取栓治疗;n=44)。观察2组临床疗效及短期预后情况,并比较治疗前、后2组血液流变学指标、美国国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS)评分及日常生活能力改良Barthel指数(modified Barthel index,MBI)评分。结果:研究组血管再通率为90.91%,高于对照组的70.73%(P<0.05);2组治疗后红细胞比容、血浆黏度及全血高切黏度均低于治疗前,且研究组低于对照组(均P<0.05);2组治疗后NIHSS评分低于治疗前,MBI评分高于治疗前,且研究组优于对照组(均P<0.05);研究组治疗后90 d预后良好率为68.18%,高于对照组的43.90%(P<0.05);治疗后90 d内,2组颅内出血、再闭塞发生率与病死率比较差异均无统计学意义(均P>0.05)。结论:替罗非班联合机械取栓治疗急性前循环脑梗死的血管再通率更高,有利于短期预后。